PT  - JOURNAL ARTICLE
AU  - Siam, Zakaria Shams
AU  - Arifuzzaman, M.
AU  - Rashid, Md. Harunur
AU  - Islam, Md. Shariful
TI  - ‘No lockdown’ policy for COVID-19 epidemic in Bangladesh : Good, bad or ugly?
AID  - 10.1101/2020.10.21.20216812
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.21.20216812
4099  - http://medrxiv.org/content/early/2020/10/23/2020.10.21.20216812.short
4100  - http://medrxiv.org/content/early/2020/10/23/2020.10.21.20216812.full
AB  - Bangladesh has been combating the COVID-19 pandemic with limited financial resources and poor health infrastructure since March, 2020. Although the government has imposed several restricted measures to curb the progression of the outbreak, these arrays of measures are not sustainable in the long run. In this study, we assess the impact of lift of flexible lockdown on the COVID-19 dynamics in Bangladesh. Our analysis demonstrates that the country might experience second infection peak in 6-7 months after the withdrawal of current lockdown. Moreover, a prolonged restrictions until January, 2021 will shift the infection peak towards August, 2021 and will reduce approximately 20 % COVID-19 cases in Bangladesh.What we knowBangladesh has been going through COVID-19 crisis and in response, the Government has implemented restricted array of measures to curb the COVID-19 outbreak in Bangladesh.What this article addsThe impact of ‘no lockdown’ policies on COVID-19 pandemic in Bangladesh.Appearance of second infection peak in 6-7 months after the withdrawal of current lockdown.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicableFunding StatementThe authors declare that no funding was received in order to pursue this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data are available with the manuscript